Notice of Intent to Award a Sole Source Contract to IRUBIS GmbH

Back to opportunities

NoticeNo Set aside used1

Notice of Intent to Award a Sole Source Contract to IRUBIS GmbH

HEALTH AND HUMAN SERVICES, DEPARTMENT OF › FOOD AND DRUG ADMINISTRATION

Posted Jun 1, 2026

Due Jun 15, 2026

Silver Spring, MD

NAICS 334516

Sol # FDA-133409

AI Summary

• The FDA requires the Purchase of a MONIPA_1 Protein Concentration Analyzer for laboratory use.
• Acquisition is set aside for sole source under NAICS 562710 (Biotechnology Research and Development).
• Analysis must be performed using IRUBIS GmbH's proprietary technology located in Germany.

Description

The Food and Drug Administration (FDA) intends to award a Sole Source firm-fixed price commercial Purchase Order (PO) to IRUBIS GmbH, Bayerstrasse 85A, Munchen, Bavaria 80335, Germany for the Purchase of a MONIPA_1 Protein Concentration Analyzer. Please review the attached Intent to Sole Source FDA-133409 document for more information.

Classification

NAICS334516

Place of Performance

CitySilver Spring

StateMD

ZIP20993

CountryUNITED STATES

Contracting Office

OfficeFOOD AND DRUG ADMINISTRATION

CityRockville

StateMD

ZIP20841

Contacts

Janice Heard

janice.heard@fda.hhs.gov

2157173093

Attachments (1)

Attachment 1